The issue was subscribed 8.45 times, with bids received for 145 million shares against the total issue size of 17 million shares, data available with the NSE as of 5 pm showed.
The largest number of bids came in from foreign institutional investors (FIIs) under the qualified institutional buyers (QIBs) quota, which was subscribed 24.4 times. The retail category was subscribed 1.5 times, while the non-institutional category, which includes investment from high net-worth individuals was subscribed 3.6 times as of 5 pm, a merchant banker handling the issue said.
“We got one of the best anchor books for the issue, with several long-term investors supporting it. Investors are bullish on the healthcare space, especially hospitals, and Narayana Hrudayalaya has a unique business model and the backing of good quality management,” said Dharmesh Mehta, managing director and chief executive officer, Axis Capital.
Narayana Hrudayalaya had raised Rs 184 crore from 15 anchor investors last week, including the government of Singapore and a number of domestic mutual funds, at Rs 250, upper end of the price band. The IPO had set a price band of Rs 245-250 for the sale.
Nearly a fourth of the issue is an offer for sale from existing promoters, including founder-chairman Devi Shetty and institutional shareholders Ashoka Investment and Ambadevi Mauritius. The merchant bankers to the issue were Axis Capital, IDFC Securities and Jefferies India.
This is the third IPO in the healthcare segment in the past month, with earlier issues of Alkem Laboratories and Dr. Lal Path Labs getting oversubscribed 44 and 33 times, respectively. Both issues were offer for sale from existing shareholders and didn’t involve issue of fresh shares.
Healthcare IPOs have seen robust demand from all investor segments in contrast to recent marquee offerings of InterGlobe Aviation and Coffee Day Enterprises which were given a miss by retail investors.
Experts suggest that investors in healthcare IPOs are betting on an increase in demand for healthcare services on the back of rising incomes in the country.
KEY TAKEAWAYS
- This is the third issue of a health care firm to sail through this month
- The largest number of bids came from FIIs under the QIBs quota, which was subscribed 24.4 times
- Narayana Hrudayalaya had raised Rs 185 crore from 15 anchor investors last week
- Experts say investors are betting on increase in demand on the back of rising incomes
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)